RE: The clever are quickly buying right now22 Nov 2024 14:12
Shareholders with less than 400 shares will lose their positions
Urgent need for funding indicating financial pressure
Dilution risk from potential 50% pre-emption rights disapplication
Failure to pass resolutions would compromise clinical trial financing